InvestorsHub Logo

GD

Followers 25
Posts 863
Boards Moderated 0
Alias Born 07/12/2002

GD

Re: sts66 post# 230055

Monday, 11/25/2019 4:20:52 PM

Monday, November 25, 2019 4:20:52 PM

Post# of 430576
You are under estimating Inclisiran peak sales, Repathas Q3 sales
grew 40% from last to $186M and I am sure will reach $1B sales next
year, Inclisiran is much better than Repatha, IMO.
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AMRN News